Vimarsana
Biggest News Aggregation in the World

John Karanicolas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from John Karanicolas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In John Karanicolas Today - Breaking & Trending Today

The Wistar Institute: Wistar Scientists Discover Innate Tumor Suppression Mechanism - Vimarsana News

The Wistar Institute: Wistar Scientists Discover Innate Tumor Suppression Mechanism

Findings could benefit African Americans who possess a specific genetic variant of p53PHILADELPHIA, PA, May 04, 2023, a journal of the American Association for Cancer Research, researchers at The Wistar

TRIANA Biomedicines, Inc.: TRIANA Biomedicines Attracts Leading Protein Science and Clinical Oncology Experts to its Scientific Advisory Board - Vimarsana News

TRIANA Biomedicines, Inc.: TRIANA Biomedicines Attracts Leading Protein Science and Clinical Oncology Experts to its Scientific Advisory Board

Robert A. Copeland, PhD and Adrian M. Senderowicz, MD join Scientific Advisory BoardWALTHAM, MA / ACCESSWIRE / June 23, 2022 / TRIANA Biomedicines, Inc. (TRIANA), a leading biopharmaceutical company focused

TRIANA Biomedicines Attracts Leading Protein Science and Clinical Oncology Experts to its Scientific Advisory Board - Vimarsana News

TRIANA Biomedicines Attracts Leading Protein Science and Clinical Oncology Experts to its Scientific Advisory Board

Press release content from Accesswire. The AP news staff was not involved in its creation.

Source: apnews.com
Fox Chase Cancer Center's John Karanicolas Awarded University City Science Center Grant | Fox Chase Cancer Center - Vimarsana News

Fox Chase Cancer Center's John Karanicolas Awarded University City Science Center Grant | Fox Chase Cancer Center

PHILADELPHIA (February 24, 2022)—John Karanicolas, PhD, co-leader of the Molecular Therapeutics research program at Fox Chase Cancer Center, has been awarded a $200,000 grant as part of the University City Science Center’s QED Proof-of-Concept Program. The grant will fund research into developing antibodies that could be activated selectively in a tumor by a small molecule.

Students at Lewis Katz School of Medicine stand to benefit from new $1 million NIGMS grant - Vimarsana News

Students at Lewis Katz School of Medicine stand to benefit from new $1 million NIGMS grant

Students at Lewis Katz School of Medicine stand to benefit from new $1 million NIGMS grant Rapid evolution in the field of biomedical research demands well-trained scientists. Adapting biomedical research training programs to keep up with the increasingly complex and interdisciplinary nature of the field, however, presents complex challenges for higher-education institutions. The Lewis Katz School of Medicine at Temple University, home to highly skilled researchers and professors and known for its collaborative atmosphere, has long been on the cutting edge of biomedical research. Now, PhD and...